Singapore - English - HSA (Health Sciences Authority)

link healthcare singapore pte ltd - methylnaltrexone bromide - injection, solution - 12mg/0.6ml - methylnaltrexone bromide 12mg/0.6ml

European Union - English - EMA (European Medicines Agency)

bausch health ireland limited - methylnaltrexone bromide - opioid-related disorders; constipation - peripheral opioid receptor antagonists - treatment of opioid-induced constipation in advanced-illness patients who are receiving palliative care when response to usual laxative therapy has not been sufficient.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

swedish orphan biovitrum ltd - methylnaltrexone bromide - solution for injection - 20mg/1ml

Canada - English - Health Canada

salix pharmaceuticals inc - methylnaltrexone bromide - solution - 20mg - methylnaltrexone bromide 20mg - miscellaneous gi drugs

Canada - English - Health Canada

salix pharmaceuticals inc - methylnaltrexone bromide - solution - 20mg - methylnaltrexone bromide 20mg - miscellaneous gi drugs

Canada - English - Health Canada

salix pharmaceuticals inc - methylnaltrexone bromide - solution - 20mg - methylnaltrexone bromide 20mg - miscellaneous gi drugs

New Zealand - English - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - methylnaltrexone bromide 12mg (12mg in 0.6ml) - solution for injection - 12 mg/0.6ml - active: methylnaltrexone bromide 12mg (12mg in 0.6ml) excipient: glycine hydrochloric acid sodium calcium edetate sodium chloride sodium hydroxide water for injection - relistor is indicated for the treatment of opioid-induced constipation in patients with advanced illness who are receiving palliative care when response to laxative therapy has not been sufficient.